熱點掃描 | 商湯、泉峯、聖諾上市首日表現均佳
uSMART盈立智投12月30日消息,截止發稿,港股三大指數漲跌互現,恆生指數上漲0.48%,報23196.36點,成交額282.56億;恆生科技指數上漲0.87%,報5519.43點,成交額48.68億;紅籌指數下跌0.14%報3911.55點,成交額5.87億。
商湯科技開盤一度漲超21%,領漲恆生科技板塊,公司市值超1500億港元。商湯科技是一家專注於計算機視覺軟件的人工智能軟件公司。根據弗若斯特沙利文公司的報告,按2020年收入口徑,商湯科技爲亞洲最大的人工智能軟件公司,並以2020年11%的收入市場份額成爲中國最大的計算機視覺軟件提供商。
泉峯控股開盤後一度漲近24%,成交額近5億港元。於往績記錄期間,泉峯控股的收入大幅增長,盈利能力顯著改善。公司的收入由2018年的6.907億美元增至2020年的12.009億美元,複合年增長率爲31.9%。
聖諾醫藥一度漲近5%,是全球領先的RNA療法生物製藥公司,爲大陸RNA療法第一股。
綠電板快漲幅居前,大唐發電漲近6%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.